Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer

Overview of attention for article published in Frontiers in immunology, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 36,978 followers.

Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer #lymphoma #lymsm https://t.co/JaUeObFFdz

24 Jul 2021

Reply Repost Favourite

New article: Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer https://t.co/y159sFzunN #melanoma #oncology https://t.co/R5d4usKPuV

23 Jul 2021

Reply Repost Favourite

RT @FrontImmunol: New Research: Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refr…

06 Jul 2021

Reply Repost Favourite

New Research: Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer: There is limited experience of PD-1 antibody combined with other therapies in children. We aimed to… https://t.co/Yluish

06 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.